Impact of Evaporation on the Performance of Ant Colony Optimization-Based Routing Protocols on the Wireless Sensor Network

Wireless Sensor Network (WSN) has the characteristics limited computing, memory and energy, so a routing protocol that supports WSN network performance is needed. Routing protocols based Ant Colony Optimization (ACO) are very suitable for use in WSN for routing data packets. In this report, we will try out several kinds of parameter values that bear on the pheromone evaporation (ρ) on the ACO algorithms applied to the WSN routing protocol with grid topology on the number of nodes variables in the WSN network. Where this can increase the number of delivery packets on a busy WSN network and each node transmits a packet continuously. From the results, the value of ρ 0.75 makes WSN performance on the grid topology with the number of nodes 12 and 30 very good in terms of the delivery packet, but with the number of nodes 70 the value of ρ 0.70 makes WSN performance better than the delivery packet side

Feline immunodeficiency virus (FIV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management

Despite the passage of over 30 years since its discovery, the importance of feline immunodeficiency virus (FIV) on the health and longevity of infected domestic cats is hotly debated amongst feline experts. Notwithstanding the absence of good quality information, Australian and New Zealand (NZ) veterinarians should aim to minimise the exposure of cats to FIV. The most reliable way to achieve this goal is to recommend that all pet cats are kept exclusively indoors, or with secure outdoor access (e.g., cat enclosures, secure gardens), with FIV testing of any in-contact cats. All animal holding facilities should aim to individually house adult cats to limit the spread of FIV infection in groups of animals that are stressed and do not have established social hierarchies. Point-of-care (PoC) FIV antibody tests are available in Australia and NZ that can distinguish FIV-infected and uninfected FIV-vaccinated cats (Witness™ and Anigen Rapid™). Although testing of whole blood, serum or plasma remains the gold standard for FIV diagnosis, PoC testing using saliva may offer a welfare-friendly alternative in the future. PCR testing to detect FIV infection is not recommended as a screening procedure since a negative PCR result does not rule out FIV infection and is only recommended in specific scenarios. Australia and NZ are two of three countries where a dual subtype FIV vaccine (Fel-O-Vax® FIV) is available and offers a further avenue for disease prevention. Since FIV vaccination only has a reported field effectiveness of 56% in Australia, and possibly lower in NZ, FIV-vaccinated cats should undergo annual FIV testing prior to annual FIV re-vaccination using a suitable PoC kit to check infection has not occurred in the preceding year. With FIV-infected cats, clinicians should strive to be even more thorough than usual at detecting early signs of disease. The most effective way to enhance the quality of life and life expectancy of FIV-infected cats is to optimise basic husbandry and to treat any concurrent conditions early in the disease course. Currently, no available drugs are registered for the treatment of FIV infection. Critically, the euthanasia of healthy FIV-infected cats, and sick FIV-infected cats without appropriate clinical investigations, should not occur

Adhesive capsulitis of the shoulder and diabetes: a meta-analysis of prevalence

Background: adhesive capsulitis (AC) results in progressive painful restriction in range of movement and can reduce function and quality of life. Whilst it has been associated with diabetes mellitus (DM), there is considerable variation in the reported prevalence of AC in the diabetic population. The aim of this study is to determine through meta-analysis the prevalence of AC in DM and examine whether it is influenced by type of DM or insulin therapy. We also aim to further establish the prevalence of DM in patients presenting with AC. Methods: we conducted a literature search for terms regarding AC and DM on Embase and Pubmed NCBI. Results: of 5411 articles identified, 18 were selected. Meta-analysis showed that patients with DM were 5 (95% CI 3.2-7.7) times more likely than controls to have AC. The overall prevalence of AC in DM was estimated at 13.4% (95% CI 10.2- 17.2%). Comparison of prevalence in patients on insulin vs other treatments showed no significant difference between the two. Meta-analysis estimated the prevalence of DM in AC at 30% (95% CI 24-37%). Conclusion: to our knowledge this is the first meta-analysis to estimate the overall prevalence of diabetes in a population with AC. A high prevalence of AC exists in DM and equally a high prevalence of DM is present in AC. Screening for DM should be considered in patients presenting with A

Magnetic ordering of Mn sublattice, dense Kondo lattice behavior of Ce in (RPd3)8Mn (R = La, Ce)

We have synthesized two new interstitial compounds (RPd3)8Mn (R = La and Ce). The Mn ions present in "dilute" concentration of just 3 molar percent form a sublattice with an unusually large Mn-Mn near neighbor distance of ~ 85 nm. While the existence of (RPd3)8M (where M is a p-block element) is already documented in the literature, the present work reports for the first time the formation of this phase with M being a 3d element. In (LaPd3)8Mn, the Mn sub-lattice orders antiferromagnetically as inferred from the peaks in low-field magnetization at 48 K and 23 K. The latter peak progressively shifts towards lower temperatures in increasing magnetic field and disappears below 1.8 K in a field of ~ 8 kOe. On the other hand in (CePd3)8Mn the Mn sublattice undergoes a ferromagnetic transition around 35 K. The Ce ions form a dense Kondo-lattice and are in a paramagnetic state at least down to 1.5 K. A strongly correlated electronic ground state arising from Kondo effect is inferred from the large extrapolated value of C/T = 275 mJ/Ce-mol K^2 at T = 0 K. In contrast, the interstitial alloys RPd3Mnx (x = 0.03 and 0.06), also synthesized for the first time, have a spin glass ground state due to the random distribution of the Mn ions over the available "1b" sites in the parent RPd3 crystal lattice.Comment: 18 figures and 20 pages of text documen

Geometrical statistics of the vorticity vector and the strain rate tensor in rotating turbulence

We report results on the geometrical statistics of the vorticity vector obtained from experiments in electromagnetically forced rotating turbulence. A range of rotation rates $\Omega$ is considered, from non-rotating to rapidly rotating turbulence with a maximum background rotation rate of $\Omega=5$ rad/s (with Rossby number much smaller than unity). Typically, in our experiments ${\rm{Re}}_{\lambda}\approx 100$. The measurement volume is located in the centre of the fluid container above the bottom boundary layer, where the turbulent flow can be considered locally statistically isotropic and horizontally homogeneous for the non-rotating case, see van Bokhoven et al., Phys. Fluids 21, 096601 (2009). Based on the full set of velocity derivatives, measured in a Lagrangian way by 3D Particle Tracking Velocimetry, we have been able to quantify statistically the effect of system rotation on several flow properties. The experimental results show how the turbulence evolves from almost isotropic 3D turbulence ($\Omega\lesssim 0.2$ rad/s) to quasi-2D turbulence ($\Omega\approx 5.0$ rad/s) and how this is reflected by several statistical quantities. In particular, we have studied the orientation of the vorticity vector with respect to the three eigenvectors of the local strain rate tensor and with respect to the vortex stretching vector. Additionally, we have quantified the role of system rotation on the self-amplification terms of the enstrophy and strain rate equations and the direct contribution of the background rotation on these evolution equations. The main effect is the strong reduction of extreme events and related (strong) reduction of the skewness of PDFs of several quantities such as, for example, the intermediate eigenvalue of the strain rate tensor and the enstrophy self-amplification term.Comment: 17 pages, 6 figures, 3 table

Epidemiology of Stroke in the MENA Region: A Systematic Review.

Introduction: Stroke is a major burden on the health system due to high fatality and major disability in survivors. Whilst Stroke incidence has declined in the developed world, it continues to increase in developing nations, including the MENA (Middle East and North Africa) region. This may reflect different risk factors and strategies to treat and manage patients prior to and after Stroke. Methods: We have conducted a systematic review of the prevalence, incidence and mortality of Stroke in the 23 countries of MENA region following the PRISMA guidelines. Results: 8,874 published papers were retrieved through both PubMed and Embase. Of those, 38 studies were found to be eligible for inclusion in this review. Only thirteen countries in the MENA region had data points for the critical stroke parameters. Of these qualified studies, 14 were prospective, population-based studies. In the age-adjusted studies, incidence ranged widely between 16/100,000 in a prospective population-based in Iran to 162/100,000 in Libya. Age-adjusted prevalence was available only from Tunisia at 184/100,000. Mortality for all strokes from the eight countries reporting this measure found the 30 day-case fatality ranged from 9.3% in Qatar to 30% in Pakistan. Most stroke studies in the MENA region were small sized, hospital-based, lacked confidence intervals and did not provide prevalence and mortality figures. Conclusion: National policymakers, public health and medical care stakeholders need more reliable epidemiologic studies on Stroke from the MENA region to plan more effective preventive and therapeutic strategies

Improving the screening and treatment of hypertension in people living with HIV: An evidence-based policy brief by Malawi’s Knowledge Translation Platform

No Abstrac

Consistent perturbations in an imperfect fluid

We present a new prescription for analysing cosmological perturbations in a more-general class of scalar-field dark-energy models where the energy-momentum tensor has an imperfect-fluid form. This class includes Brans-Dicke models, f(R) gravity, theories with kinetic gravity braiding and generalised galileons. We employ the intuitive language of fluids, allowing us to explicitly maintain a dependence on physical and potentially measurable properties. We demonstrate that hydrodynamics is not always a valid description for describing cosmological perturbations in general scalar-field theories and present a consistent alternative that nonetheless utilises the fluid language. We apply this approach explicitly to a worked example: k-essence non-minimally coupled to gravity. This is the simplest case which captures the essential new features of these imperfect-fluid models. We demonstrate the generic existence of a new scale separating regimes where the fluid is perfect and imperfect. We obtain the equations for the evolution of dark-energy density perturbations in both these regimes. The model also features two other known scales: the Compton scale related to the breaking of shift symmetry and the Jeans scale which we show is determined by the speed of propagation of small scalar-field perturbations, i.e. causality, as opposed to the frequently used definition of the ratio of the pressure and energy-density perturbations.Comment: 40 pages plus appendices. v2 reflects version accepted for publication in JCAP (new summary of notation, extra commentary on choice of gauge and frame, extra references to literature

Progress of Advanced Nanomaterials in the Non-Enzymatic Electrochemical Sensing of Glucose and H2O2

Non-enzymatic sensing has been in the research limelight, and most sensors based on nanomaterials are designed to detect single analytes. The simultaneous detection of analytes that together exist in biological organisms necessitates the development of effective and efficient non-enzymatic electrodes in sensing. In this regard, the development of sensing elements for detecting glucose and hydrogen peroxide (H2O2) is significant. Non-enzymatic sensing is more economical and has a longer lifetime than enzymatic electrochemical sensing, but it has several drawbacks, such as high working potential, slow electrode kinetics, poisoning from intermediate species and weak sensing parameters. We comprehensively review the recent developments in non-enzymatic glucose and H2O2 (NEGH) sensing by focusing mainly on the sensing performance, electro catalytic mechanism, morphology and design of electrode materials. Various types of nanomaterials with metal/metal oxides and hybrid metallic nanocomposites are discussed. A comparison of glucose and H2O2 sensing parameters using the same electrode materials is outlined to predict the efficient sensing performance of advanced nanomaterials. Recent innovative approaches to improve the NEGH sensitivity, selectivity and stability in real-time applications are critically discussed, which have not been sufficiently addressed in the previous reviews. Finally, the challenges, future trends, and prospects associated with advanced nanomaterials for NEGH sensing are considered. We believe this article will help to understand the selection of advanced materials for dual/multi non-enzymatic sensing issues and will also be beneficial for researchers to make breakthrough progress in the area of non-enzymatic sensing of dual/multi biomolecules.Scopu

Novel insights on diagnosis, cause and treatment of diabetic neuropathy: Focus on painful diabetic neuropathy

Diabetic neuropathy is common, under or misdiagnosed, and causes substantial morbidity with increased mortality. Defining and developing sensitive diagnostic tests for diabetic neuropathy is not only key to implementing earlier interventions but also to ensure that the most appropriate endpoints are employed in clinical intervention trials. This is critical as many potentially effective therapies may never progress to the clinic, not due to a lack of therapeutic effect, but because the endpoints were not sufficiently sensitive or robust to identify benefit. Apart from improving glycaemic control, there is no licensed treatment for diabetic neuropathy, however, a number of pathogenetic pathways remain under active study. Painful diabetic neuropathy is a cause of considerable morbidity and whilst many pharmacological and nonpharmacological interventions are currently used, only two are approved by the US Food and Drug Administration. We address the important issue of the ‘placebo effect’ and also consider potential new pharmacological therapies as well as nonpharmacological interventions in the treatment of painful diabetic neuropathy